Lung cancer specialist Mark Socinski, of the University of Pittsburgh Cancer Institute, discusses how screening for lung cancer has evolved in the past few years, and how it can benefit individuals at high risk for lung cancer.
Lung cancer specialist Mark Socinski, of the University of Pittsburgh Cancer Institute, discusses how screening for lung cancer has evolved in the past few years, and how it can benefit individuals at high risk for lung cancer.
"We had a very nice study, the National Lung Cancer Screening Study, that showed a 20 percent reduction in deaths from lung cancer," he says. The study included individual aged 55 to 70 and smoked at least 30-pack years.
He encourages individuals to talk to their doctor about lung cancer screening and if they should be tested.
Traditional Definition of ‘High-Risk’ in Patients With CLL and SLL Outdated, Needs to be Revisited
December 7th 2020In an interview with CURE®, Dr. Jan A. Burger discusses how the results of two phase 3 studies could help redefine what constitutes as low or high risk in patients with CLL or SLL.
Read More
To gain a better understanding of the issues faced by geriatric patients with cancer, and to determine how much of a role nutrition plays in outcomes, Dr. Grant Williams, a geriatrician oncologist and assistant professor at the University of Alabama, Birmingham, worked with colleagues to create a patient-reported assessment tool that bridges the knowledge gap in this patient population.
Read More